These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28586268)

  • 1. Biopolitics and Boundary Work in South Africa's Sutherlandia Clinical Trial.
    Morris C
    Med Anthropol; 2017 Oct; 36(7):685-698. PubMed ID: 28586268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells.
    Chinkwo KA
    J Ethnopharmacol; 2005 Apr; 98(1-2):163-70. PubMed ID: 15763378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sutherlandia frutescens: the meeting of science and traditional knowledge.
    Aboyade OM; Styger G; Gibson D; Hughes G
    J Altern Complement Med; 2014 Feb; 20(2):71-6. PubMed ID: 23837689
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of traditional medicinal plant extracts on antiretroviral drug absorption.
    Brown L; Heyneke O; Brown D; van Wyk JP; Hamman JH
    J Ethnopharmacol; 2008 Oct; 119(3):588-92. PubMed ID: 18640255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial.
    Wilson D; Goggin K; Williams K; Gerkovich MM; Gqaleni N; Syce J; Bartman P; Johnson Q; Folk WR
    PLoS One; 2015; 10(7):e0128522. PubMed ID: 26186450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae).
    van Wyk BE; Albrecht C
    J Ethnopharmacol; 2008 Oct; 119(3):620-9. PubMed ID: 18761068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Mechanism and Pathway of the Interaction between the African Traditional Medicine, Sutherlandia Frutescens, and the Antiretroviral Protease Inhibitor, Atazanavir, in Human Subjects Using Population Pharmacokinetic (PK) Analysis.
    Muller AC; Ducharme MP; Kanfer I
    J Pharm Pharm Sci; 2018; 21(1s):215s-221s. PubMed ID: 30158052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: implications for absorption and metabolism.
    Müller AC; Patnala S; Kis O; Bendayan R; Kanfer I
    J Pharm Pharm Sci; 2012; 15(2):221-33. PubMed ID: 22579002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulating polysaccharides from Lessertia frutescens leaves: isolation, characterization and structure activity relationship.
    Zhang B; Leung WK; Zou Y; Mabusela W; Johnson Q; Michaelsen TE; Paulsen BS
    J Ethnopharmacol; 2014 Mar; 152(2):340-8. PubMed ID: 24480566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology.
    Mills E; Cooper C; Seely D; Kanfer I
    Nutr J; 2005 May; 4():19. PubMed ID: 15927053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential signaling involved in Sutherlandia frutescens-induced cell death in MCF-7 and MCF-12A cells.
    Vorster C; Stander A; Joubert A
    J Ethnopharmacol; 2012 Mar; 140(1):123-30. PubMed ID: 22266339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.
    Ntuli SSBN; Gelderblom WCA; Katerere DR
    BMC Complement Altern Med; 2018 Mar; 18(1):93. PubMed ID: 29544492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial and antioxidant activity of Sutherlandia frutescens (Fabaceae), a reputed anti-HIV/AIDS phytomedicine.
    Katerere DR; Eloff JN
    Phytother Res; 2005 Sep; 19(9):779-81. PubMed ID: 16220570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affect and the "Really Real": The Politics of HIV/AIDS Framing in South African Theater.
    Ruthven JS
    Med Anthropol; 2017; 36(8):729-743. PubMed ID: 28777656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-stimulatory activity of a polysaccharide-enriched fraction of Sutherlandia frutescens occurs by the toll-like receptor-4 signaling pathway.
    Lei W; Browning JD; Eichen PA; Lu CH; Mossine VV; Rottinghaus GE; Folk WR; Sun GY; Lubahn DB; Fritsche KL
    J Ethnopharmacol; 2015 Aug; 172():247-53. PubMed ID: 26096188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent use of Antiretroviral and African traditional medicines amongst people living with HIV/AIDS (PLWA) in the eThekwini Metropolitan area of KwaZulu Natal.
    Mncengeli S; Manimbulu NM; Panjasaram N
    Afr Health Sci; 2016 Dec; 16(4):1118-1130. PubMed ID: 28479905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract.
    Ojewole JA
    Methods Find Exp Clin Pharmacol; 2004; 26(6):409-16. PubMed ID: 15349136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The social construction of ARVs in South Africa.
    Sember R
    Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sangomas: problem or solution for South Africa's health care system.
    Cook CT
    J Natl Med Assoc; 2009 Mar; 101(3):261-5. PubMed ID: 19331259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. South Africa's "rollout" of highly active antiretroviral therapy: a critical assessment.
    Nattrass N
    J Acquir Immune Defic Syndr; 2006 Dec; 43(5):618-23. PubMed ID: 17019364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.